Trials / Completed
CompletedNCT00612625
Near Normalisation of BG Improves the Potentiating Effect of GLP-1
Near Normalisation of Blood Glucose Improves the Potentiating Effect of GLP-1 on Glucose Induced Insulin Secretion in Patients With Type 2 Diabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- Hvidovre University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The ability of glucagon-like peptide 1 to enhance beta-cell responsiveness to I.v. glucose is impaired in patients with type 2 diabetes mellitus compared with healthy individuals. We investigated whether 4 weeks of near-normalisation og blood glucose improves the potentiation of glucose-stimulated insulin secretion by GLP-1
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | glucagon-like peptide-1 | continuous infusion of GLP-1 (1½ pmol/kg/min) |
| DRUG | Saline | continuous infusion of saline |
Timeline
- Start date
- 2004-02-01
- Primary completion
- 2004-07-01
- Completion
- 2004-12-01
- First posted
- 2008-02-12
- Last updated
- 2008-02-12
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00612625. Inclusion in this directory is not an endorsement.